Related references
Note: Only part of the references are listed.Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
Victoria L. Campodonico et al.
INFECTION AND IMMUNITY (2010)
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
INFECTION AND IMMUNITY (2009)
Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
Andrew Y. Koh et al.
INFECTION AND IMMUNITY (2009)
Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
Jerry D. King et al.
INNATE IMMUNITY (2009)
Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
VACCINE (2009)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
Vaccines and immunotherapy against Pseudomonas aeruginosa
Gerd Doering et al.
VACCINE (2008)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity
Gerald B. Pier
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis
Adrian W. Zuercher et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants
NT Liberati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
N Safdar et al.
CRITICAL CARE MEDICINE (2005)
Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia
AY Koh et al.
INFECTION AND IMMUNITY (2005)
The galU gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung
GP Priebe et al.
INFECTION AND IMMUNITY (2004)
Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains
GB Pier et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
AB Lang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia
SL Mueller-Ortiz et al.
INFECTION AND IMMUNITY (2004)
Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen
GB Pier
CARBOHYDRATE RESEARCH (2003)
Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine
C Theilacker et al.
INFECTION AND IMMUNITY (2003)
O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa
K Faure et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant
GP Priebe et al.
INFECTION AND IMMUNITY (2003)
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV
DW Frank et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung
EES Nieuwenhuis et al.
NATURE MEDICINE (2002)
Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine
GP Priebe et al.
INFECTION AND IMMUNITY (2002)
Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa
YA Knirel et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
M Allewelt et al.
INFECTION AND IMMUNITY (2000)
Functional conservation of the polysaccharide biosynthetic protein WbpM and its homologues in Pseudomonas aeruginosa and other medically significant bacteria
LL Burrows et al.
INFECTION AND IMMUNITY (2000)
Structural characterization of the outer core and the O-chain linkage region of lipopolysaccharide from Pseudomonas aeruginosa serotype O5
I Sadovskaya et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
